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Abstract
Receptors of the signalling lymphocyte-activation molecules (SLAM) family are involved in the functional regulation of a
variety of immune cells upon engagement through homotypic or heterotypic interactions amongst them. Here we show
that murine cytomegalovirus (MCMV) dampens the surface expression of several SLAM receptors during the course of the
infection of macrophages. By screening a panel of MCMV deletion mutants, we identified m154 as an immunoevasin that
effectively reduces the cell-surface expression of the SLAM family member CD48, a high-affinity ligand for natural killer (NK)
and cytotoxic T cell receptor CD244. m154 is a mucin-like protein, expressed with early kinetics, which can be found at the
cell surface of the infected cell. During infection, m154 leads to proteolytic degradation of CD48. This viral protein interferes
with the NK cell cytotoxicity triggered by MCMV-infected macrophages. In addition, we demonstrate that an MCMV mutant
virus lacking m154 expression results in an attenuated phenotype in vivo, which can be substantially restored after NK cell
depletion in mice. This is the first description of a viral gene capable of downregulating CD48. Our novel findings define
m154 as an important player in MCMV innate immune regulation.
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Introduction
Pathogens have recourse to innumerable tactics for evading host
immune surveillance. Viruses, and in particular large DNA viruses
such as herpesviruses, are endowed with the capacity to encode
multiple products committed to altering, during all stages of their
life cycle, several functions of the innate and adaptive immune
system. The homeostatic equilibrium achieved between host
immune responses and viral immune escape mechanisms empow-
ers these viruses to successfully establish their characteristic lifelong
infections. Human cytomegalovirus (CMV), the prototype b-
herpesvirus, usually leads to asymptomatic infections in healthy
individuals where it remains in a latent state for life, going through
sporadic reactivation and leading to severe diseases in immuno-
compromised patients [1,2]. The generation of an efficient host-
elicited immune response against CMV includes the induction of
natural killer (NK) cells, antibody and T-cell mediated responses
[3]. As a consequence, CMV has evolved diverse countermeasures
to avoid recognition by T cells, allowing it to interfere with the
surface expression of major histocompatibility complex class I
(MHC class I) and class II and costimulatory molecules, com-
promising antigen presentation [3–6]. Likewise, the virus counteracts
NK cell triggering, primarily by suppressing the expression of
ligands for activating receptors while preserving engaged inhibitory
receptors [7–9]. In addition, CMV alters the function of cytokines
and their receptors, and interacts with complement factors. While
great strides have been made in recent years in identifying CMV
inhibitors of immune response mechanisms, current consensus is
that among the vast amount of genetic CMV material still requiring
a functional assignment, the virus harbours as yet uncovered
immunoevasins directed against already known or new immuno-
logical targets. Due to the species-specific nature of human CMV
(HCMV) replication, infection of mice with murine CMV (MCMV)
has proven to be an invaluable model for studying aspects of the
biology underlying CMV infection. In this regard, the MCMV
system has been widely used to unveil new immunomodulatory
molecules and to explore their roles in infection and viral path-
ogenesis [10].
The signalling lymphocyte-activation molecules (SLAM) family
of cell-surface receptors is a distinct structural subgroup of the
immunoglobulin (Ig) superfamily differentially expressed on
hematopoietic cells and found to play pivotal roles in both innate
and adaptive immunity [11–13]. Among other activities, SLAM
immunomodulatory receptors regulate cell adhesion, cytokine
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production, and cytotoxicity of NK and CD8+ T cells. The SLAM
family currently consists of nine members, CD48, CD84, CD150
(SLAM), CD229, CD244 (2B4), CD319 (CRACC), CD352
(SLAMF6, NTB-A; Ly108), CD353 (BLAME) and SLAMF9.
One of the hallmarks of this class of receptors is that they interact
with members of the same family via their amino-terminal Ig-V
domains. While most of them are typically self-ligands, partici-
pating in homophilic interactions, CD48 is a heterophilic receptor
for CD244 [14]. The cytoplasmic domain of most SLAM family
members carry one or more copies of a distinctive immunor-
eceptor intracellular tyrosine-based switch motif (ITSM) [13,15].
Upon receptor engagement, these motifs undergo phosphorylation
and recruit with high affinity and specificity adaptor molecules like
the SLAM-associated protein (SAP) [11,16].
In particular, CD48 is a GPI-anchored glycoprotein with
expression in a broad range of cells of the hematopoietic lineage,
especially on antigen-presenting cells [17]. CD244, the high-
affinity counter receptor of CD48 both in humans and mice, is a
transmembrane surface glycoprotein with an intracellular tail
containing four ITSMs. It is highly expressed on NK cells, and to a
lesser extent on other cytotoxic cells such as CD8+ T cells, baso-
phils, and eosinophils. CD244 is an important activating receptor
for the regulation of CD8+ T and mature NK cells, promoting cell-
mediated cytotoxicity and cytokine release [18–20]. Engagement
of CD244 by its ligand leads to the polarization and release of
cytolytic granules into the contact zone between NK and target
cells [21].
SLAM family receptors have been shown to play specific roles
in viral pathogenesis. Various morbilliviruses, including the highly
contagious measles virus, employ CD150 as the principal receptor
to enter into a subset of immune cells, facilitating their spread and
contributing to viral-induced immunosuppression [22,23]. In
response to Epstein-Barr virus infection, CD48 is strongly induced
on the surface of B lymphocytes and may aid viral trafficking [24].
In addition, we have recently shown that HCMV encodes UL7, a
CD229 structural homologue capable of interfering with proin-
flammatory responses [25]. The role of SLAM receptors in
antiviral immunity has been clearly documented in the X-linked
lymphoproliferative syndrome, a rare immunodeficiency human
disease in which impaired signalling functions of the SLAM
receptors, stemming from mutations in the SAP-encoding gene, is
associated with an extreme sensitivity to infection with Epstein-
Barr virus [26]. Therefore, since SLAM receptors are active
components of host immunity, viruses might have evolved immune
evasion manoeuvres to specifically ablate triggering of such
receptors. Indeed, this is the case for HIV-1, which utilizes Vpu
to elude NK cell recognition through the downregulation of NTB-
A expression on the surface of infected CD4+ T cells [27].
Whether this is a more generalized phenomenon and what con-
sequences modulating SLAM receptors may cause in the infected
host remain unknown.
In this study we show that MCMV infection efficiently decreases
the expression of several SLAM family receptors at the cell surface
of macrophages, and we pinpoint m154 as the viral downregulator
of CD48. We found that m154 helps to debilitate the effectiveness of
anti-MCMV triggered NK cell responses, thereby meliorating viral
growth in vivo. Thus, we present here a novel strategy evolved by
CMV to subvert detection by NK cells during acute infection, based
on the modulation of a SLAM family member.
Results
Expression of SLAM receptors on the surface of mouse
peritoneal macrophages
SLAM family members are differentially expressed among
hematopoietic cells. As macrophages play a key role in MCMV
infection with regard to viral replication, dissemination, and the
establishment of latency [28–30], and constitute one of the prin-
cipal effectors of innate immunity, we selected this particular cell
type to explore potential SLAM perturbations upon MCMV
infection. Using flow cytometry, we first assessed whether CD48,
CD84, CD150, CD229, CD244 and Ly108 were present on the
surface of thioglycollate-elicited peritoneal macrophages. The lack
of a commercially available antibody against CD319, CD353, and
SLAMF9 prevented the study of these receptors in this cell type.
As shown in Figure 1A, the SLAM receptors CD48, CD84,
CD229, and Ly108 were expressed on the macrophage surface,
whereas CD150 and CD244 could not be detected. We found
however, that CD150 was present at the surface of LPS-treated
mouse peritoneal macrophages (data not shown), consistent with
earlier studies [31]. Thus, peritoneal macrophages represent an
MCMV permissive cell type expressing a number of SLAM
receptors, allowing us to examine whether members of this family
could be targets for modulation during MCMV infection.
Substantial reduction of cell-surface expression of SLAM
receptors during the course of MCMV infection
We then infected peritoneal macrophages with MCMV-GFP at
a multiplicity of infection (moi) of 2. The use of MCMV-GFP,
based on the bacterial artificial chromosome (BAC)-cloned MCMV
genome pSM3fr-GFP, which contains a GFP gene inserted within
the ie2 locus [32], allowed us to track and selectively analyze infected
cells in the cultures. Under these conditions, infection rates reached
approximately 50%. At different times (24 h, 48 h, and 72 h) after
infection, cells were stained for the surface expression of CD48,
CD84, CD229, and Ly108. Notably, MCMV infection resulted in
the significant progressive downregulation of all the four receptors
analyzed over the course of the infection, when compared to both
non-infected cells (GFP negative) from the same culture (Figure 1B)
or with mock-infected macrophages (data not shown). Surface
reductions in CD84 and Ly108 were already observed at 24 h post-
infection (hpi), and at 48 hpi for CD48 and CD229, becoming for
all four receptors more pronounced at 72 hpi. Thus, by 72 hpi
macrophages demonstrated a dramatic loss in expression of the four
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elude the host immune response and guarantee its
survival. The signalling lymphocyte-activation molecules
(SLAM) family of receptors encompasses a number of
adhesion molecules expressed on the surface of leuko-
cytes that play critical roles in both innate and adaptive
immunity. In this study, we report that murine CMV
drastically reduces the expression of several SLAM family
receptors at the cell surface of infected macrophages,
most likely as part of its immunoevasion mechanisms. We
have identified a murine CMV gene product (m154) that
downregulates CD48, a SLAM family member that func-
tions as a ligand of CD244, a molecule involved in the
regulation of natural killer (NK) and cytotoxic T cell
functions. We show that during infection, m154 targets
CD48 for degradation. Moreover, this viral protein con-
tributes to increased MCMV growth during acute infection
in the mouse by protecting against NK cell mediated
surveillance. These findings are important for better
understanding CMV pathogenesis, and provide a novel
example of host innate immune subversion by CMV.
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SLAM receptors analyzed. As expected [6], a significant surface
decrease in MHC class I molecules was also detected in infected
cells. Similar results were obtained when experiments were
performed with wild-type (wt) MCMV not expressing GFP (data
not shown).
We further analyzed the effect of the viral dose on the alteration
of SLAM surface expression by infecting peritoneal macrophages
at different mois, ranging from 0.5 (,5% infected macrophages) to
5 (,70% infected macrophages), with MCMV-GFP. As depicted
in Figure 2A, there was a strong dependency on the viral dose for
cell-surface reduction of SLAM receptor expression concomitant
with the downmodulation of MHC class I, which in turn
correlated with the extent of infected peritoneal macrophages.
To determine whether viral gene expression was required for
SLAM downregulation, macrophages were treated with UV-
inactivated MCMV. The results showed no decrease in CD48,
CD84, CD229, or Ly108 surface expression after infection of
macrophages for 72 h with the UV-inactivated virus (Figure 2B),
indicating that SLAM downregulation could be attributed to
specific MCMV genome-encoded products. Moreover, for Ly108,
cell-membrane expression levels after infection with UV-inacti-
vated MCMV were even higher than those of uninfected cells,
most likely due to the viral-dependent macrophage activation (data
not shown).
Altogether these results show that MCMV encodes gene
products that efficiently diminish the cell-surface levels of SLAM
family members.
Identification of m154 as the MCMV gene that interferes
with CD48 cell-surface expression
Since CD244, the high affinity receptor for CD48, is expressed
in NK and cytotoxic CD8+ T cells known to play a prominent role
in the clearance of MCMV infection, we decided to further
explore the consequences of the cell-surface depletion of CD48,
and sought to identify the viral product(s) causing it.
The potential modulators of SLAM receptors would most likely
be genes dispensable for viral replication in vitro. Thus, to identify
the MCMV gene product(s) that might mediate the downregula-
tion of CD48, we systematically screened the viral genome
utilizing a panel of mutant viruses bearing deletions of approx-
imately 10–15 kbp each in non-essential regions. These mutant
viruses were based on the BAC-cloned MCMV genome contain-
ing the GFP. Peritoneal mouse macrophages were infected with
wild-type and mutant MCMVs, and at 72 hpi were tested for
surface expression of CD48. After infection with the deletion
mutant MCMV-GFPDm144-m158 (Figure 3A) missing genes
extending from m144 to m158, cell-surface CD48 was restored,
reaching levels comparable to that of non-infected cells (Figure 3B).
As expected, due to the lack of the m147.5 gene this deletion
mutant was also capable to revert the cell-surface expression of
CD86 [33], whereas it did not significantly affect the downreg-
ulation of other SLAM receptors, such as Ly108. At this point,
three additional viral mutants, MCMV-GFPDm144-m148,
MCMV-GFPDm149-m153, and MCMV-GFPDm154-m157 all
containing smaller specific deletions within the m144-m157 region
(from m144 to m148, from m149 to m153, and from m154 to m157,
respectively) (Figure 3A) were assessed for their capability to
interfere with CD48. As shown in Figure 3B, only the MCMV
mutant in which the genetic region encompassing m154 to m157
was removed, efficiently relieved CD48 downregulation, while
levels of CD86 remained similar to those present in wt MCMV-
infected macrophages. CD86, however, was not reduced from the
macrophage surface after infection with either MCMV-
GFPDm144-m148 or MCMV-GFPDm149-m153, mutants that
do lack the m147.5 gene. To further narrow down the possible
viral CD48 downregulators, we examined two additional viral
mutants containing deletions within the m153-m157 genomic
region, MCMV-GFPDm153-m154 and MCMV-GFPDm155-
m157 (Figure 3A and data not shown). Notably, the MCMV
Figure 1. MCMV infection leads to reduced expression of SLAM
receptors on the macrophage surface. (A) Surface expression of
the SLAM receptors CD48, CD84, CD150, CD229, CD244, and Ly108 on
peritoneal macrophages was tested by flow cytometry using specific
mAbs against each of these molecules (black line histograms). Isotype
IgGs directly conjugated with PE or APC were used as negative controls
(dashed line histograms). A representative experiment out of three
performed is shown. (B) Peritoneal macrophages were mock-infected or
infected with MCMV-GFP at an moi of 2 and analyzed by flow cytometry
at 24, 48 and 72 hours after infection for surface expression of CD48,
CD84, CD229, Ly108, and MHC class I (MHC I) as indicated in A. Open
histograms represent the expression of these molecules on MCMV-
infected (GFP-positive) cells, and shaded histograms represent the
expression on uninfected (GFP-negative) cells from the same culture.
doi:10.1371/journal.ppat.1004000.g001
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mutant lacking m153 and m154 genes, but not the viral mutant
missing genes m155 to m157, reverted CD48 downregulation
(Figure 3B, and data not shown). As a role of the m153 gene in
CD48 cell-surface alteration had been excluded after analyzing
MCMV-GFPDm149-m153, we deduced that the m154 gene
product was the one leading to reduced macrophage-surface
expression of CD48 during MCMV infection. This observation
was confirmed with a viral mutant bearing a deletion in m154,
MCMVDm154 (Figure 3A), which was able to ablate downreg-
ulation of CD48 to an extent comparable to that of mock-infected
cells, whereas it maintained the downregulation of Ly108 and
CD84 (Figure 3C). As Tang and co-workers [34] in a reassessment
of global MCMV ORFs using DNA microarray analysis reported
two additional small ORFs, m154.3 and m154.4, potentially
expressed in infected NIH 3T3 cells, that partially overlapped with
ORF m154 and which therefore were interrupted in the deletion
Figure 2. MCMV-induced downmodulation of SLAM receptors correlates with the extent of infection and depends on viral gene
expression. (A) Peritoneal macrophages were mock-infected or infected for 72 h with MCMV-GFP at the different moi indicated, and analyzed by
flow cytometry for surface expression of CD48, CD84, CD229, Ly108 and MHC class I (MHC I) as described in Figure 1. Black line histograms represent
the expression of these molecules on the total number of cells alive in the cultures (including both MCMV-infected GFP-positive cells and uninfected
GFP-negative cells), and dashed line histograms represent isotype controls. Micrographs of the corresponding infections are shown in the right
panels. (B) Same as in A, except that an moi of 10 was used, and macrophages were also exposed for 72 h to the same amount of MCMV-GFP UV-
inactivated. Open histograms represent the expression of these molecules on MCMV-infected cells from the MCMV-GFP treated cultures and shaded
histograms represent the total number of cells alive in the MCMV-GFP UV-inactivated exposed cultures. Isotype IgGs were used as negative controls
(dashed line histograms). A micrograph of the MCMV-GFP infection at an moi of 10 (GFP-positive,,95% in the culture) is shown on the right panel. A
representative experiment out of two performed is shown.
doi:10.1371/journal.ppat.1004000.g002
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Figure 3. Deletion of m154 results in decreased CD48 surface density on MCMV-infected macrophages. (A) Schematic depiction of the
region between the m144 and m158 genes in parental MCMV-GFP or wt MCMV, MCMV-GFPDm144-m158, MCMV-GFPDm144-m148, MCMV-
GFPDm149-m153, MCMV-GFPDm154-m157, MCMV-GFPDm153-m154, MCMVDm154, and MCMVDm154Int used in the analysis. (B) Peritoneal
macrophages were mock-infected or infected for 72 h with MCMV-GFP, MCMV-GFPDm144-m158 MCMV-GFPDm144-m148, MCMV-GFPDm149-m153,
MCMV-GFPDm154-m157, and MCMV-GFPDm153-m154 at an moi of 2 and analyzed by flow cytometry for surface expression of CD48, Ly108, or CD86
as described in Figure 1. Open histograms represent the expression of these molecules on infected (GFP-positive) cells and shaded histograms
m154 Downregulates CD48 and Permits NK Cell Escape
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mutant MCMVDm154, a new recombinant MCMV carrying a
smaller internal deletion in m154 that preserved intact both m154.3
and m154.4 (MCMVDm154Int) was generated. In a manner
similar to MCMVDm154, MCMVDm154Int did not significantly
alter CD48 surface levels (Figure 3C). These data further
confirmed that the observed rescue of CD48 surface density in
infected macrophages was the result of deleting the m154 gene.
Thus, we concluded that m154 abrogates the surface expression of
CD48.
Characterization of the m154 gene product
The m154 gene belongs to the m145 gene family [35],
comprised of eleven members, some of which encode molecules
that adopt an MHC class I fold [36] and which are known to be
involved in the modulation of immune responses. In contrast to
other members of this family, the m154 gene has no homology
with MHC class I genes. It encodes a 368-aa type I transmem-
brane protein with a 23-aa putative N-terminal signal peptide, a
300-aa ectodomain, a 23-aa transmembrane domain, and a 22-aa
C-terminal cytoplasmic tail (Figure 4A). The ectodomain is a
mucin-like domain displaying a striking number of serine (29) and
threonine (84) residues that are potential O-linked glycosylation
sites, and contains one putative N-glycosylation site (at position
161). A search of the available sequence databases using the m154
deduced amino acid sequence revealed no significant degree of
sequence identity between m154 and other known viral or host
proteins.
In order to examine m154 expression during the viral infection,
we raised a specific monoclonal antibody (mAb; m154.4.113)
against the protein, using a peptide corresponding to its cyto-
plasmic tail as an immunogen. Peritoneal macrophages, either
mock-infected or infected for 72 h with wt MCMV, were analyzed
by Western blot with this mAb. A single protein band with an
apparent molecular mass of ,60 kDa was detected only in the
infected cell (Figure 4B). The migration of the detected protein
differed from the predicted size of the mature m154, which is
38 kDa, being highly suggestive of an extensive glycosylation
occurring via its copious serine and threonine residues. To identify
the expression kinetic class of m154, we infected macrophages in
the presence of either the viral DNA synthesis inhibitor phos-
phonoacetic acid (PPA), which prevents late viral gene expression,
or the protein translation inhibitor cycloheximide (CHX), which
selectively limits viral gene expression to immediate early genes. As
shown in Figure 4B, m154 was not recovered after release from
the CHX block in the presence of actinomycin D, whereas under
these conditions, the major immediate early MCMV protein IE1
was abundantly found, as expected. m154, however, was readily
detected after PPA treatment, indicating that this viral protein is
expressed with early kinetics.
Infected macrophages were also examined by indirect immu-
nofluorescence to determine the subcellular localization of m154.
The protein was strongly expressed on the cell membrane and to a
lesser extent in the cytoplasm (Figure 4C). Biotin-labelling of
proteins on the surface of wt MCMV-infected macrophages,
followed by immunoprecipitation with the anti-m154 mAb, SDS-
PAGE, and subsequent Western blot probed with labelled
streptavidin, confirmed the presence of m154 at the cell surface
(Figure 4D). Localization of m154 on the cell surface was also
observed after ectopic expression of m154. Thus, when 300.19 cells
stably transfected with an HA-m154 fusion protein containing the
influenza hemagglutinin (HA) epitope tag inserted at the N-
terminal end of m154 were analyzed by flow cytometry using an
anti-HA antibody, a cell-surface pattern of HA staining was
observed (Figure 4E). It must be noted, however, that when
expressed in isolation, m154 exerted no overt effects on the surface
levels of CD48, which was constitutively expressed in 300.19 cells
(Figure 4F). This result suggests the need of additional MCMV
encoded proteins or virally induced cellular molecules for m154 to
operate appropriately.
To asses the ability of m154 to downregulate CD48 when
ectopically expressed in the context of an MCMV infection, we
generated a viral mutant (MCMVm154Ectop, Figure 5A) in which
we inserted the m154 ORF plus 210 nt of its corresponding
putative promoter and 60 nt including its putative polyA signal,
into the genome of MCMVDm154 behind the ie2 ORF. As shown
in Figure 5B, MCMVm154Ectop largely reduced CD48 macro-
phage-surface levels when examined at 72 hpi, time at which
m154 could be clearly detected by indirect immunofluorescence in
the MCMVm154Ectop-infected cell, where it displayed a distri-
bution comparable to that observed during wt MCMV infection
(compare Figure 5C and Figure 4C).
Based on all these findings, we concluded that m154, the
MCMV downregulator of CD48, is an early-phase mucin-like protein
with a predominant cell-surface localization in the infected cell.
m154 downregulates CD48 via a degradation route
Although MCMV-encoded products with immunomodulatory
properties are not believed to play a role in the viral replication
cycle, we analyzed whether m154 affected MCMV growth in tissue
culture. To this end, single-step growth curves of MCMVDm154
and wt viruses were determined in mouse embryo fibroblasts
(MEFs) and peritoneal macrophages after infection at a low moi.
MCMVDm154 displayed plaque morphologies in MEFs and
growth kinetics in both cell types that were indistinguishable from
those of wt virus, confirming the lack of involvement of m154 in the
viral replication cycle (Figure 6A and data not shown).
In addressing the mechanism by which m154 downregulates
CD48, we first considered the possibility that this viral protein may
affect CD48 transcription. However, when we compared CD48
RNA levels in wt MCMV-infected macrophages with mock-
infected cells by reverse transcriptase (RT)-PCR, we found no
substantial change in CD48 mRNA content (Figure 6B). This
observation suggested that CD48 expression was being altered
through post-transcriptional mechanisms. Therefore, we examined
CD48 protein in cell lysates of wt MCMV-infected cells at
different time points by using Western blot. As depicted in
Figure 6C, CD48 (,40 kDa band) levels were drastically lower in
total cell lysates of infected macrophages, especially after 48 h of
infection. This decrease in CD48 occurred concomitantly with the
appearance of m154, which was readily detected 48 h after
infection, reaching a maximum at 72 hpi and then continuing to
accumulate in the infected cell. Thus, the data pointed towards
proteolytic degradation of CD48 during MCMV infection. To
assess which protein degradation pathway was involved, we used
represent the expression on uninfected (GFP-negative) cells from the same cultures. A representative experiment out of at least two performed is
shown. (C) Same as in B, except that infections were performed with wt MCMV, MCMVDm154, MCMVDm154Int at an moi of 10 and analyzed by flow
cytometry for surface expression of CD48, Ly108, and CD84. Open histograms represent the expression of these molecules on infected cultures and
shaded histograms represent the expression on uninfected cultures. Isotype IgGs were used as negative controls (dashed line histograms). A
representative experiment out of three performed is shown.
doi:10.1371/journal.ppat.1004000.g003
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proteasomal or lysosomal proteolysis inhibitors. MG-132 is con-
sidered a specific 26S proteasome inhibitor, while leupeptin is a
reversible and competitive intralysosomal proteolysis inhibitor that
specifically blocks serine and some cysteine proteases. As revealed
by Western blotting, treatment with MG-132 was able to signi-
ficantly restore CD48 expression (Figure 6D). We also observed
however, that the presence of leupeptin partially abrogated CD48
degradation. Consistent with these findings, immunofluorescence
Figure 4. Analysis of MCMVm154. (A) The deduced amino acid sequence of m154 is shown, with the predicted leader peptide in yellow and the
transmembrane region in blue. The putative N-linked glycosylation site (underlined) and O-glycosylation sites (bold) are indicated. (B) Peritoneal
macrophages were mock-infected (mock) or infected with wt MCMV at an moi of 10 in the absence (lane -) or presence of cycloheximide and
actinomycin D (lane CHX), or phosphonoacetic acid (lane PPA). Cell lysates were prepared at 72 hpi, except for the cycloheximide treated samples
that were collected 16 hpi, separated under reducing conditions by SDS-PAGE (10%), and transferred to a nitrocellulose membrane. The blot was
proved with the anti-m154 mAb or anti-MCMV IE1 (Croma 101) mAb followed by anti-mouse IgG HRP. A mAb anti-b-actin followed by an anti-rabbit
IgG HRP was used as an internal control. (C) Peritoneal macrophages, either mock-infected or infected with wt MCMV at an moi of 10 for 72 h, were
fixed, permeabilized, and stained with anti-m154 mAb followed by an anti-mouse IgG Alexa fluor 555. Nuclei were stained with the DAPI reagent. The
cells were examined under a microscope at 405 nm (DAPI, panels a and d) and at 555–565 nm (Alexa-555, panels b and e). The overlaid images are
shown in panels c and f. (610 magnification). (D) Peritoneal macrophages, either mock-infected (mock) or infected with wt MCMV at an moi of 10,
were surface-labeled with biotin. Cell lysates were prepared at 72 hpi and subjected to immunoprecipitation with anti-m154 mAb, followed by SDS-
PAGE (10%) separation and Western blot analysis as indicated in B, using streptavidin-POD conjugate. Molecular weights in kilodaltons are indicated.
(E) Flow cytometry analysis of 300.19 cells stably transfected with empty pDisplay vector expressing HA (left panel) or the construct HA-m154 (right
panel) and stained after 24 h with biotin anti-HA mAb (black line) or isotype control (dashed line) followed by streptavidin-PE. (F) 300.19 cells non-
transfected (shaded histogram) or stably transfected with the construct HA-m154 (black line histogram) were analyzed by flow cytometry for surface
expression of CD48 as indicated in Figure 1. The corresponding isotype was used as a negative control (dashed line histogram).
doi:10.1371/journal.ppat.1004000.g004
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microscopy assays evidenced enhanced CD48 signals in the wt
MCMV-infected macrophages exposed to the two different
proteolysis inhibitors (Figure 6E, panels j and n) as compared to
that of the untreated-infected cells (Figure 6E, panel f). Moreover,
co-localization of m154 and CD48 could be clearly visualized in
both MG-132 and leupeptin treated-infected macrophages (see
panels l and p in Figure 6E). Altogether, the data indicate that
MCMV targets CD48 for degradation, likely using both the
proteasome- and the lysosome-mediated mechanisms.
Absence of m154 augments the susceptibility of MCMV-
infected macrophages to NK cell-mediated
degranulation
As indicated, the natural ligand for CD48 is CD244, a molecule
that is expressed on all NK cells, and to a lesser extent, on other
cytotoxic leukocytes. We first sought to explore whether infection
of macrophages with MCMV resulted in a reduced recognition by
CD244 due to the loss of CD48 on the cell surface. For this
purpose, we generated a soluble murine CD244-Fc fusion protein
containing the ectodomain of CD244 fused to the Fc portion of the
human IgG. As shown in Figure 7A, binding of CD244-Fc fusion
protein to macrophages was significantly decreased upon wt
MCMV infection. On the other hand, the fusion protein inter-
acted with MCMVDm154- and MCMVDm154Int-infected cells
in a similar manner to non-infected cells (Figure 7A).
The interaction of CD48 with CD244 increases NK cell
activation, triggering cytotoxicity. Thus, by suppressing CD48-
surface expression, m154 could help MCMV elude NK cell-
mediated immune responses. To ascertain whether this was the
case, we compared the degranulation capacity of NK cells after
exposure to macrophages infected with wt MCMV or MCMVDm154.
For this purpose, we used a flow cytometric-based assay to measure
NK cell-surface expression of LAMP-1 (CD107a). NK cells purified
from mouse spleens were incubated with mock-, wt MCMV- or
MCMVDm154-infected cells at a macrophage/NK ratio of 1:1. As
expected, the percentage of CD107a+ NK cells specifically
augmented in response to the viral infection as compared to non-
infected cultures. No substantial differences could be detected,
Figure 5. The m154 gene ectopically expressed within the MCMVDm154 genome decreases CD48 surface levels on MCMV-infected
macrophages. (A) Schematic depiction of MCMVm154Ectop, with an expansion of the m153-m155 region (represented by an open box) to show
the deletion of the m154 gene, and of part of the MIE region (represented by a black box) to indicate the location of the m154 gene inserted
(together with 210 nt of its corresponding putative promoter and 60 nt including its putative polyA signal [pA]) in between the ie2 and the m129
genes. The major IE promoter (MIEP) is marked. (B) Peritoneal macrophages were mock-infected or infected for 72 h with wt MCMV or
MCMVm154Ectop at an moi of 10 and analyzed by flow cytometry for surface expression of CD48 as described in Figure 1. Shaded histograms
represent CD48 expression on mock-infected cells, and black line and dotted-line histograms represent CD48 expression on cells from wt MCMV- and
MCMVm154Ectop-infected macrophages, respectively. Isotype IgG was used as a negative control (dashed line histograms). A representative
experiment out of two performed is shown. (C) Peritoneal macrophages, infected with MCMVm154Ectop at an moi of 10 for 72 h, were fixed,
permeabilized, and stained with anti-m154 mAb followed by an anti-mouse IgG Alexa fluor 555, and analyzed as indicated in Figure 4C. Shown are
nuclei stained with the DAPI reagent (left panel), cultures stained for m154 (middle panel), and the overlaid image (right panel). Images were
captured at 406magnification.
doi:10.1371/journal.ppat.1004000.g005
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Figure 6. CD48 undergoes proteolytic degradation during MCMV infection. (A) MEFs and peritoneal macrophages were infected at an moi
of 0.025 or 0.1, respectively with wt MCMV and MCMVDm154. At the indicated days after infection the amount of extracellular (MEFs) or cell-
associated (macrophages) infectious virus present in the cultures was determined. Each data point represents the average and standard deviation of
three separate cultures. (B) Peritoneal macrophages were mock-infected or infected with wt MCMV at an moi of 10 for 72 h. Whole-cell RNA was
harvested, treated with DNase and reverse-transcribed using oligo(dT). PCRs were performed using primer sets specific for murine CD48, m154, and
b-actin. The amplified products were separated on agarose gels and visualized with ethidium bromide staining. As shown, specific PCR-amplified
products were not detected in control reactions in which the reverse transcriptase (RT) was not added during the reverse transcription reaction. (C)
Peritoneal macrophages were mock-infected or infected with wt MCMV at an moi of 10. At the indicated time points after infection, cell lysates were
prepared, and subjected to Western blot analysis as indicated in Figure 4B using an anti-mouse CD48 mAb or the anti-m154 mAb followed by anti-
Armenian hamster HRP or by anti-mouse IgG HRP, respectively. A mAb anti-b-actin followed by anti-rabbit IgG HRP was used as an internal control.
(D) Peritoneal macrophages were mock-infected (mock) or infected with wt MCMV at an moi of 10 in the absence (-) or presence of MG-132 or
leupeptin. Cell lysates were prepared at 72 hpi and subjected to Western blot analysis as indicated in C. (E) Peritoneal macrophages were mock-
infected or infected with wt MCMV at an moi of 10 for 72 h. When indicated, cultures were treated with MG-132 or leupeptin. Cells were fixed,
permeabilized, and stained with anti-CD48-Alexa Fluor 488, and anti-m154 mAb followed by an anti-mouse IgG Alexa fluor 555, and analyzed as
indicated in Figure 4C. Shown are representative cells from cultures stained for m154 (panels a, e, i, and m), for CD48 (panels b, f, j, and n), nuclei
stained with the DAPI reagent (panels c, g, k, and o), and overlaid images (panels d, h, l, and p). Images were captured at 406magnification.
doi:10.1371/journal.ppat.1004000.g006
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however, in any of the experiments performed, when we compared
the percentage of CD107a+ NK cells incubated with wt MCMV
and those incubated with mutant MCMV-infected macrophages
(e.g. mock: 5.5%61.7; wt MCMV: 31.6%62.9; MCMVDm154:
26.3%61.3). In contrast, we observed markedly increased CD107a
externalization in the NK cell population responding to the m154
defective MCMV, as indicated by a 2-fold increase in the CD107a
mean fluorescence intensity (MFI) on the CD107a+ NK cells
exposed to MCMVDm154-infected cultures as compared to wt
MCMV (Figure 7B and 7C). Thus, the mean number of granules
discharged by individual degranulating NK cells during stimulation
by MCMV-infected macrophages was lower when m154 was being
expressed. To evaluate whether the effects on NK-cell responses
observed were caused by m154 acting on the CD48/CD244 axis,
we performed degranulation assays on co-cultures of NK cells and
MCMVDm154-infected cells pre-incubated with the CD244-Fc
fusion protein. As shown in Figure 7D, the CD244-Fc fusion protein
partially blocked CD107a surface expression on NK cells exposed to
the MCMVDm154-infected cells, while an irrelevant control Fc
fusion protein did not have a significant impact. Together, the
results indicate that m154 contributes to confer protection to
MCMV-infected macrophages against NK cell attack, and that
these effects are mediated, at least in part, through m154 down-
regulation of CD48.
m154 enhances in vivo MCMV growth by protecting
against NK cell-mediated control
We reasoned that reduction of CD48 surface expression on
antigen-presenting cells may contribute to the host’s impaired
ability to control viral growth. We therefore sought to explore the
impact that m154 plays in the context of an acute viral infection by
inoculating BALB/c mice with MCMVDm154 or wt MCMV. By
day 2 after infection, we could observe that mice intraperitoneally
(i.p.) inoculated with 26106 plaque forming units (PFU) of
Figure 7. m154-mediated downregulation of CD48 in the infected cell diminishes CD244 recognition and provokes impaired NK
degranulation. (A) Peritoneal macrophages, mock-infected (shaded histogram), infected with wt MCMV (black line histogram), MCMVDm154
(dotted line histogram) or with MCMVDm154Int (gray dashed line histogram) at an moi of 10 were labelled with 1 mg of murine biotinylated CD244-
Fc protein followed by streptavidin-PE. An unrelated biotinylated Fc fusion protein (black dashed line histogram) was used as a control. One
representative experiment out of three is shown. (B) Representative flow cytometry histograms of CD107a expression on DX5+ NK cells incubated
with mock-infected (dotted histogram), wt MCMV (black line histogram) or MCMVDm154 (shaded histogram) infected cells (moi 10) at a E/T ratio of
1:1 (C) Graph of a representative experiment out of three showing the mean (6 SEM) of MFI of CD107a+ NK cells incubated with wt MCMV (empty
bar) or MCMVDm154 (shaded bar) infected cells as indicated in B. ***p,0.001. (D) Peritoneal macrophages were mock-infected or infected with
MCMVDm154 at an moi of 10. Infected cultures were incubated with 10 mg/ml of murine CD244-Fc or of an unrelated Fc fusion protein used as a
control. Cultures were washed and exposed to the NK cells at a E/T ratio of 0.5:1. Graph of a representative experiment out of three showing the
mean (6 SEM) of the normalized percentage of CD107a+ NK cells for each sample referred to the number of CD107a+ NK cells in MCMVDm154-
infected macrophages in the absence of fusion protein. **p,0.01.
doi:10.1371/journal.ppat.1004000.g007
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MCMVDm154 had gained a larger percentage of body weight
than mice infected with the same dose of wt MCMV (Figure 8A).
Moreover, while wt MCMV-infected animals lost a substantial
percentage of body weight by days 4, 6 and 8 after infection,
animals infected with MCMVDm154 did not experienced any
weight loss during the course of the assay. Thus, at day 8 after infec-
tion the average body weight of mice infected with wt MCMV was
14.4 g64.0, whereas mice infected with MCMVDm154 had an
average body weight of 18.3 g64.3 (data not shown). In agreement
with the loss of body weight, wt MCMV-infected mice also
developed more exacerbated clinical signs of disease, such as ruffled
hair, hunched posture and lethargy (data not shown). When we
analyzed the frequency of infected peritoneal macrophages, we
did not find significant differences between wt MCMV- and
MCMVDm154-infected mice (wt MCMV: 3.0%60.6; MCMV
Dm154: 2.9%60.2). Neither, the nature of the cellular influx to the
Figure 8. In vivo attenuation of MCMVDm154 in an NK cell-dependent manner. (A) Groups of 7-weeks-old BALB/c.ByJ female mice were i.p.
inoculated with 26106 PFU of wt MCMV (open circles) or MCMVDm154 (filled circles). Changes in the percentage of body weight relative to day 0,
measured at days 2, 4, 6 and 8 post infection (pi), are shown. (B) Mice infected as indicated in A were sacrificed at days 2, 4 and 8 after infection and
viral titers from selective organs determined. The horizontal dashed line marks the limit of detection. (C) Groups of 7-weeks-old BALB/c.ByJ female
mice were i.p. inoculated with 26106 PFU of wt MCMV (open circles) or MCMVDm154Int (filled circles). Mice were sacrificed at day 4 after infection
and viral titers from the indicated organs determined. (D) Depletion of NK cells restores MCMVDm154 in vivo phenotype. Groups of 5-week-old BALB/
c.ByJ female mice were injected i.p. with anti-asialo GM1 antibody or left untreated. Animals were i.p. inoculated with 56105 PFU of wt MCMV (open
circles) or MCMVDm154 (filled circles), sacrificed at day 4 after infection and viral titers in spleen and liver determined. Values corresponding to
differences in median values between animals infected with the same virus, untreated or treated with anti-asialo GM1 antibody, are shown. *p,0.05,
**p,0.01, ***p,0.001, ns: non significant. Each symbol represents an individual mouse. Horizontal bars indicate the median values.
doi:10.1371/journal.ppat.1004000.g008
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peritoneal cavity, as determined by the levels of neutrophils
(CD11b+ Gr-1+), macrophages (CD11b+ Gr-12), T lymphocytes
(CD3+) or B lymphocytes (IgM+) appeared to be distinct amongst
the two groups of infected animals (Figure S1). We subsequently
determined the replication levels of the viral deletion mutant in
several target organs of the animals at different days post-infection.
As depicted in Figure 8B, while at day 2 post-infection, comparable
viral titers were observed in the spleens of wt MCMV- and
MCMVDm154-infected mice, at day 4 after infection, viral titers in
MCMVDm154-infected animals were around 32-, 6-, 9-, and 4-
fold lower in spleen, liver, kidney, and lung, respectively, than those
found in the same organs of wt MCMV-infected mice. Likewise, at
day 8 post-infection, viral loads of MCMVDm154 were consider-
ably lower in the organs analyzed (kidney, heart, lung, and salivary
glands) compared to those of wt MCMV. Indeed, at this time point,
viral titers were below the assay’s detection limit in a number of the
MCMVDm154-infected animals (Figure 8B). Comparable results
were obtained when mice infected with MCMVDm154Int were
analyzed at day 4 post-infection (Figure 8C). Thus, we can conclude
that MCMVs lacking the m154 gene are attenuated in all major
organs targeted during MCMV infection.
These results, showing the in vivo effects of m154 as early as 4
days post-infection, together with the in vitro data pointing to a
contribution of m154 impairing NK degranulation against the
infected macrophages, were highly indicative of an MCMV
evasion mechanism involving NK cell immune surveillance.
Therefore, we decided to examine whether the reduced attenu-
ation of MCMVDm154 was a consequence of its enhanced sus-
ceptibility to NK cells during the in vivo infection. Mice were
specifically depleted of NK cells by treatment with rabbit antiserum
to asialo GM1. Four days after infection with 86105 PFU of wt
MCMV or MCMVDm154, mice were sacrificed and assayed for
viral loads in spleen and liver, the two predominant organs in which
NK cells have been reported to intervene in the control of MCMV.
As expected, all mice treated with anti-asialo GM1 antibody had
significantly higher viral titers in their spleens and livers as com-
pared to the corresponding untreated control mice (Figure 8C).
However, the extent to which these viral titers were elevated fol-
lowing NK ablation was considerably superior in the MCMVDm154-
infected animals (in particular in the spleen, 101-fold) than in
animals infected with wt MCMV (9-fold in spleen). Thus, this
substantial restoration of MCMVDm154 replication demonstrates
that m154 promotes MCMV growth in vivo by subverting NK cell
responses.
Discussion
For an effective immune response against many viral infections,
antigen-presenting cells such as dendritic cells and macrophages
must expose a concerted repertoire of receptors that alert T and
NK cells for their efficient activation. In this context, distortion of
the surface receptor content is a maneuver widely adopted by
numerous viruses to elude the immune system and secure an
optimal milieu for their replication and dissemination. In this study
we show that several cell-surface molecules of the SLAM family,
which operate as co-signalling molecules triggering distinct signal-
transduction networks in T, NK and antigen-presenting cells, are
targeted by MCMV. Notably, CD48, CD84, CD229 and Ly108
get differentially restricted from the cell surface within the window
of time it takes for the virus to complete its life cycle and produce
productive progeny. Hence, the fact that CMV might have an
active interest in interrupting SLAM interactions through the
downregulation of the specific receptors/ligands in the infected
cell indicates that, at least for the four SLAM members analyzed in
our study, engagement of the corresponding receptors/counter
receptors should exert prevailing activating signals in key immune
cells during infection.
In this study, we decided to further explore in more detail the
loss of CD48-surface expression after MCMV infection. CD48, a
GPI-anchored molecule with broad expression in hematopoietic
cells, is a SLAM receptor not involved in the homophilic inter-
actions distinctive of this family, its natural ligand being CD244
[17]. Accordingly, reduction of CD48 from the surface of MCMV-
infected macrophages leads to a drastic decrease in CD244
binding compared to that observed in mock-infected cells. By
screening a battery of MCMV deletion mutants, we identified
m154 as the viral downregulator of CD48. Thus, deletion of both
the complete m154 sequence or of an internal part of this viral
gene from the MCMV genome is sufficient for restoring the
surface levels of CD48 back to those found in non-infected cells.
Moreover, m154 ectopically expressed within the MCMV genome
leads to a significant decrease of CD48 on the surface of the
infected macrophage. The m154 ORF encodes a type I trans-
membrane protein containing a remarkable mucin-type extracel-
lular region. By generating a specific mAb (m154.4.113) against
the cytoplasmic tail of this protein, we found that m154 expression
is initiated in the early phase of infection and continues throughout
the infection cycle, a time frame that is concomitant with the
progressive downregulation of CD48 in the infected macrophage.
In addition, we show that this viral protein preferentially localizes
on the surface of the infected cell.
m154 belongs to the m145 family of glycoproteins [35], despite
not presenting the MHC class I protein fold characteristic of some
family members. Notably, several of the ten members (m17, m145
to m158) that comprise this family have been reported to perform
immunoevasive activities [37]. In particular, the m145, m152, and
m155 proteins each downregulate one or more ligands of the
activating NK cell receptor NKG2D (H60, RAE1, or MULT-1;
[38–42]). Additionally, m152 causes intracellular retention of
MHC class I molecules [43], while m155 reduces cell-surface
expression of the costimulatory molecule CD40 [44]. Finally, the
m157 protein interacts with Ly49 NK cell receptors and engages
both NK activating (Ly49H) and inhibitory receptors (Ly49I)
[36,45,46]. Thus, m154 can be now added to the group of
molecules within the m145 family that operates as an immunoe-
vasin. While it is important to point out that m154 is able to selec-
tively downregulate CD48, since surface molecules like CD86,
Ly108, or CD84, which are used as specificity controls, are not
affected by m154, we can not exclude, however, that this viral
protein also has a multifunctional nature and targets additional
immune receptors.
In terms of delineating the mechanism that leads to the loss of
surface CD48, we determined that it does not occur at trans-
criptional level. Instead, our data show that m154 appears to be
majorly causing CD48 degradation. The viral protein leads to a
major reduction in the total cellular amount of CD48. Through
Western blot analysis and immunofluorescence microcopy, we
found that treatment of infected cells with either the serine and
cysteine protease inhibitor leupeptin or the proteasome inhibitor
MG-132 stabilizes CD48 expression in a certain degree, suggesting
that both the lysosomal and proteasomal degradation pathways
play a role in the downregulation of CD48. In addition, using
these proteolysis inhibitors, co-localization of m154 and CD48
could be appreciated in the wt MCMV-infected macrophages.
Interestingly, the m154 cytoplasmic tail displays a motif that has
been implicated in lysosomal targeting, and two overlapping
recognition sites for the adaptor protein AP-2, which is involved in
clathrin-dependent endocytosis. While the detailed mechanism by
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which m154 operates remains to be elucidated, it does not seem to
involve the overall trafficking of GPI-linked receptors, as cell-
surface expression of other GPI-anchored membrane molecules,
such as CD55, are not affected by this viral protein (data not shown).
m154 does not have a counterpart in any other of the CMV
species whose genome has been sequenced so far. However, akin
to MCMV, we have previously reported that CD48 is also
downregulated in HCMV-infected macrophages [47]. Therefore,
each CMV might have evolved its own CD48-specific inhibitor, as
yet to be identified for HCMV, emphasizing the importance of
targeting this molecule to evade NK cell recognition during infec-
tion. In addition, and similarly to MCMV, we found that other
SLAM receptors are markedly reduced from the cell surface of
macrophages upon HCMV infection (Angulo, unpublished obser-
vations). Whether the overall downmodulation of SLAM receptors
in the infected cell is an inherent and unique property of CMVs,
reflecting selection pressures faced in their specific niches, or
whether this might be used by other viruses as an immune evasion
mechanism, remains to be explored. Notably, CD48 and NTB-A
have been also reported to be negatively regulated by HIV,
leading to impaired NK cell recognition and lysis of the infected
CD4+ T cells, and being the viral accessory protein Vpu identified
as the NTB-A downregulator [27,48].
Increasing evidence indicates that CD244 contributes to the
regulation of both NK cell antiviral activity and virus-specific
CD8+ T cell functionality in humans and mice [49–51]. Engage-
ment of CD244 by CD48 in the NK cell results in the recruitment
and clustering of the receptor into lipid rafts, the phosphorylation
of the ITSMs within its intracellular tail, and the subsequent
association with the adapter molecule SAP [18,52–54]. This
triggers a signalling cascade, leading to the formation of the NK
cell synapse, which is characterized by the polarized release of
cytolytic granules containing perforin and granzymes. The NK cell
synapse is most likely critical for activated NK cells to interact in a
productive manner with MHC class I-negative target cells and
induce potent cell cytotoxicity [55]. On the other hand, CD244
can inhibit NK cell activation in the absence of functional SAP,
such as occurs in cells from patients with X-linked lymphoprolif-
erative syndrome [56]. Taken together, these observations indicate
that CD244 and SAP modulate the activity of normal NK cells.
Here, we specifically show that disruption of the m154 gene in
MCMV leads to an enhanced antiviral NK cell response in vitro. In
particular, this viral protein limits NK degranulation capacity
against MCMV-infected cultured macrophages. Moreover, we
present that the NK cell response to cells infected with the MCMV
lacking the m154 gene can be partially inhibited by preincubation
of the infected macrophages with the CD244-Fc fusion protein.
Hence, we infer from these results that by downregulating CD48,
m154 may help protect MCMV-infected cells from NK killing.
We cannot discard the possibility, however, that m154 might be
also be capable of exerting other functions that contribute to these
effects.
As expected, the m154 gene is not required for replication in vitro
and an MCMV lacking m154 has not an altered growth phenotype
in cultured MEFs or macrophages. It is of note that parental and
mutant viruses used throughout the study do all derive from
MCMV-BAC pSM3fr, containing an mck-2 frameshift mutation
associated with reduced ability to infect macrophages and a
diminished capacity to attract leukocytes [57,58]. However, the
fact that all of these recombinant MCMVs have the same pSM3fr
background makes them comparable at the level of the MCK-2
phenotype. In contrast to the in vitro observations, the severity of
the infection of viruses that do not express m154 was significantly
impaired in vivo, where they exhibited a substantial restricted
growth in all organs analyzed. By day 4 post-infection, the
differences in splenic and liver growth between wt MCMV and
MCMVDm154 were around 30- and 10-fold, respectively,
consistent with m154 counteracting NK cell responses, which
are crucial to the early control of MCMV replication. Accordingly,
we show that mice depleted of NK cells with an antibody to asialo
GM1, a glycosphingolipid present at high concentrations in this
cell population, selectively improved the in vivo replication of the
deletion mutant, confirming that the mechanism by which m154
exerts its protective role is NK cell dependent.
Because CD244 expression is not restricted to NK cells, the
impact of m154 might have implications that extend beyond the
regulation of NK cell function. This receptor is also present at
lower levels on other cytotoxic cells, such as CD8+ T cells, cd T
cells, basophils, and eosinophils. In particular, upon interaction
with CD48, CD244 helps initiate signalling and cellular cytotox-
icity in CD8+ T cells [49]. Hence, one could speculate that other
non-NK cell-related mechanisms might be also contributing to the
net protective effects of m154 in vivo. However, the fact that NK
cell depletion results in the near complete rescue of the m154-
deleted MCMV growth phenotype in vivo indicates that, at least
under the conditions of early acute infection analyzed here, the
potential of this viral protein to influence processes mediated by
other immune cell subsets might be relatively minor. It remains to
be determined whether additional effects of m154 could be of
relevance later during the infection or in other scenarios the virus
might encounter.
In summary, our study presents the SLAM family of immunor-
eceptors as a novel target of manipulation by CMV, adding to the
diversity of molecular strategies incorporated by this pathogen to
escape immune detection. We have identified for the first time a
herpesviral gene implicated in the downregulation of the SLAM
member CD48, and documented its protective role in vivo by
counteracting NK cell responses. The knowledge gained from the
findings reported in this manuscript will contribute to a better
understanding of the complex host-CMV interactions and provide
additional insights into the functioning of the SLAM receptors in
viral immunity. Finally, the identification of novel players that
increase the CMV burden early on during infection could prove
helpful for the future development of antiviral reagents.
Materials and Methods
Ethics statement
All procedures involving animals and their care were approved
(protocol number CEEA 308/12) by the Ethics Committee of the
University of Barcelona (Spain) and were conducted in compliance
with institutional guidelines as well as with national (Generalitat de
Catalunya decree 214/1997, DOGC 2450) and international
(Guide for the Care and Use of Laboratory Animals, National
Institutes of Health, 85-23, 1985) laws and policies.
Cells
The cell lines NS-1 (mouse myeloma) and 300.19 (mouse pre-B)
were obtained from the American Type Culture Collection. Cells
were grown in RPMI 1640 medium (GIBCO-BRL, Paisley, UK)
supplemented with 10% fetal bovine serum (Sigma Aldrich, St.
Louis, MO), 100 U/ml penicillin, 100 U/ml streptomycin, 1 mM
sodium pyruvate, and 2 mM L-glutamine (GIBCO-BRL). 300.19
cells were maintained in media supplemented with 0.05 mM 2-
mercaptoethanol (GIBCO-BRL). Primary mouse embryonic
fibroblasts (MEFs) were cultured in Dulbecco’s modified Eagle’s
medium (DMEM; GIBCO-BRL) supplemented as indicated above.
Primary macrophages were elicited from peritoneal exudate cells
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(PECs) following i.p. injection of 1 ml of 3% thioglycollate (Sigma
Aldrich) into BALB/c mice. PECs were removed by peritoneal
lavage. Cells were plated out at 26105 cells/ml in supplemented
RPMI 1640 medium, and incubated for 2 h at 37uC, 5% CO2, after
which nonadherent cells were washed away with phosphate
buffered saline (PBS). Macrophage preparations were confirmed
by flow cytometry using the markers F4/80 and CD11b (about 95%
were F4/80+CD11b+). NK cells were obtained from mouse spleen
using the mouse NK cell isolation kit II (Miltenyi Biotec, Bergisch
Gladbach, Germany) on an AutoMACS (Miltenyi Biotec).
Viruses
The BAC-derived MCMV, MW97.01, based on the MCMV
Smith strain (ATCC VR-1399) and referred to here as wt MCMV
[59], and the MCMV-GFP recombinant virus, a derivative of
MW97.01 carrying the GFP gene [32] were used as parental
viruses throughout the study. Recombinant strains MCMV-
GFPD6 lacking genes from m144 to m158 (referred to here as
MCMV-GFPDm144-m158), MCMV-GFPD6S1 lacking genes from
m144 to m148 (referred to here as MCMV-GFPDm144-m148),
MCMV-GFPD6S2 lacking genes from m149 to m153 (referred to
here as MCMV-GFPDm149-m153), MCMV-GFPD6S3 lacking
genes from m154 to m157 (referred to here as MCMV-GFPDm154-
m157), MCMV-GFPDm153-m154 lacking genes m153 and m154
(referred to here as MCMV-GFPDm153-m154), and MCMV-
Dm155Dm157FRT lacking genes from m155 to m157 (referred to
here as MCMV-GFPDm155-m157) have been described previ-
ously [33,40]. For the generation of recombinant MCMV lacking
m154 ORF (referred to here as MCMVDm154) a kanamycin
resistance (KanR) cassette was amplified from the plasmid pGP704
with primers Dm154Fw (59- CCC GCC AAT CAC ATT CAC
GAG GGG GTG CTC CGA GAT ACG GTC TCG ACC ACA
GGA CGA CGA CGA CAA GTA -39) and Dm154Rv (59- CAC
ATA AGA CTC GTC ATA ACC TTC CCC GAG TGC CAC
CTC CCC ACC CTT ATC GTC TCA GGA ACA CTT AAC -
39) (underlined letters are homologous to the MCMV genome). For
the generation of recombinant MCMV lacking only ORF m154
and without affecting ORFs m154.3 and m154.4 described in Tang
et al. [34], referred to here as MCMVDm154Int, a KanR cas-
sette was amplified from the pGP704 with following primers:
Dm154bFw (59- CCG CTG CGG ACG CGA TCT CTT CGG
CAA CCC CTA GTG CAG GTG CCG TTA GGA CGA CGA
CGA CAA GTA A -39) and Dm154Rv. PCR fragments were
inserted into the m154 ORF of the MCMV BAC MW97.01 by red-
a, -b, -c-mediated recombineering [60]. Subsequently, the KanR
cassette was excised by FLP recombinase. For MCMVm154Ectop,
the m154 ORF plus sequences containing the putative promoter
and the polyadenylation signal were PCR amplified using primers
m154-ek.for (59- CGC GTT AAC CCC GTA TAA ACA CCG
CAC CAG A -39) and m154-ek.rev (59- CGC AGA TCT ATG
TCC TGA CAG ATT ATC GTG GT -39) with MW97.01 DNA
as a template. The PCR product was cloned into pOri6K-F5 [61]
and then the m154 sequences together with the adjacent KanR
cassette (flanked by mutant [F5] FRT sites) was amplified using
primers m154-ins.for (59- AAC CAC GGG TTC TTT CTC TTG
ACC AGA GAC CTG GTG ACC GTC AGG AAG AAG ATT
CAG TGA CAG GAA CAC TTA ACG GCT GA -39) and m154-
ins.rev (59- GTC CGA TGA ATA AAA CCT CTT TAT TTA
TTG ATT AAA AAC CAT GAC ATA CCT CGT GTC CTC
CCC GTA TAA ACA CCG CAC CA -39). The m154 sequences
and the KanR cassette were inserted downstream of the ie2 (m128)
ORF of the MCMVDm154 BAC by red-a, -a, -c-mediated
recombineering followed by excision of KanR as described above.
The integrity of the MCMVDm154, and MCMVDm154Int, and
MCMVm154Ectop genomes was verified by restriction analysis
and sequencing. Viral stocks were prepared by infecting MEFs at
low moi. Cell supernatants were recovered when maximum
cytopathic effect was reached, and cleared of cellular debris by
centrifugation at 1.7506g for 10 min. Viral titers were determined
by standard plaque assays on MEFs. Peritoneal macrophages were
infected with parental MCMV, MCMV-GFP or derived deletion
mutants at an moi ranging from 0.2 to 10. Adsorption was for 2 h at
37uC, 5% CO2, including a centrifugal enhancement of infectivity
step [62]. Cells were then washed in PBS before fresh medium was
added. The percentage of macrophages infected by recombinant
viruses not expressing GFP was estimated by indirect immunoflu-
orescence 24 h after infection using the anti-MCMV IE1 mAb
Croma 101 followed by goat anti-mouse IgG Alexa Fluor-488. UV-
inactivation of virus was performed using a UV crosslinker (HL
2000 hybrilinker, UVP [254 nm UV], Upland, CA) for 3 min at
360 mJ/cm2.
Antibodies
The anti-m154 mAb (clone m154.4.113, IgG2a) was generated
by fusing an NS-1 myeloma cell line with spleen cells from a
BALB/c mouse immunized three times with the synthetic peptide
corresponding to the intracellular tail of m154 (HRWEDDKG-
GEVALGEGYDESYV) conjugated to KLH (Proteogenix, Ober-
husbergen, France). The hybridoma was subcloned at least three
times. The following mAbs were obtained from Biolegend (San
Diego, CA): anti-mouse CD48-PE, anti-mouse CD48-Alexa Fluor
488, CD84-PE, Ly108-PE, H2-PE, CD150-PE, CD86-PE, F4/80-
pacific blue, CD49b-PE/Cy7, CD107a-Alexa Fluor 488, CD3-
Alexa Fluor 647, and streptavidin-PE. Biotin anti-mouse 2B4,
recognizing mouse CD244, anti-mouse CD229-APC, CD11b-PE,
and Gr-1-APC were purchased from Becton Dickinson Bioscience
(San Diego, CA), anti-mouse CD48 (HM48-1) from Santa Cruz
Biotechnology (Santa Cruz, CA), and IgM-FITC from Southern
Biotech (Birmingham, AL). Anti-mouse IgG Alexa fluor 555 and
anti-mouse IgG-Alexa Fluor 488 were purchased from Invitrogen
(Carlsbad, CA). Anti-rabbit IgG and anti-Armenian hamster IgG
(H+L) labelled with horseradish peroxidase (HRP) were obtained
from Jackson Immuno Research Laboratories (West Grove, PA),
and anti-mouse IgG (H+L) labelled with HRP from Promega
(Heidelberg, Germany). Biotin-conjugated anti-HA and anti-
mouse b-actin were purchased from Sigma Aldrich. Isotype
control IgGs directly conjugated with the corresponding fluoro-
chromes were obtained from Immunotools (Friesoythe, Germany).
The MCMV IE1 specific mAb Croma 101 has been previously
described [63].
Plasmid constructions and transfections
A murine CD244-Fc fusion protein containing the CD33 leader
peptide and the Fc region of human IgG1 was obtained by
inserting sequences corresponding to the CD244 ectodomain into
the mammalian expression vector signal pIg-Tail (R&D Systems,
Wiesbaden, Germany) as previously described [64]. The construct
corresponding to the Ig fusion protein was subcloned into the
expression vector pCI-neo. An NS-1 stable transfectant secreting
the CD244-Fc fusion protein was obtained by electroporation and
selection using 1.2 mg/ml geneticin (G418) (GIBCO-BRL). Eight
million cells were electroporated (280V, 950 mF) with 8 mg of
linearized DNA using the Gene Pulser II Apparatus (Bio-Rad,
Hercules, CA). The transfected cells were plated in flat-bottom,
96-well tissue culture plates (Costar, Corning, NY) by limiting
dilution and the clone producing the highest amounts of fusion
protein was cultured in INTEGRA CL 1000 flasks (Integra
Biosciences AG, Chur, Switzerland). The supernatant containing
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the fusion protein was purified using the Affi-Gel Protein-A MAPS
II kit (Bio-Rad). An m154 N-terminal HA fusion protein (HA-
m154) was constructed using a PCR product of m154 obtained
with primers m154BglII (59- CCA AGA TCT TTG GGT CGT
TTA GAG CTT -39) containing a BglII restriction site, and
m154PstI (59- CTC CTG CAG TCA CAC ATA AGA CTC
GTC -39) containing a PstI restriction site, and DNA extracted
from MCMV virions as a template. The PCR product was
inserted into the pGEMT vector and a BglII-PstI fragment
corresponding to the m154 gene without the signal peptide was
then excised and inserted in frame with the HA at the N-terminal
end of the m154 protein into the mammalian expression vector
pDisplay (Invitrogen) treated with BglII and PstI. 300.19 stable
transfectants were obtained using the same protocol as indicated
for NS-1 cells, except that plasmids expressing HA-m154 or the
corresponding empty pDisplay vector were transfected using the
Amaxa Cell Line Nucleofector Kit V (Amaxa AG, Koeln,
Germany) according to the manufacturer’s protocol, and selection
performed with 0.8 mg/ml of G418.
Flow cytometry analysis
Flow cytometry was performed using standard procedures. Fc
fusion protein stainings were performed using 2 mg of biotinylated Ig
fusion protein followed by incubation with streptavidin-PE. Samples
were analyzed using a FACSCanto II (BD Biosciences) flow
cytometer and processed with the accompanying FlowJo software
(Tree star Inc, Ashland, OR). Ten thousand cells were counted for
each sample. Cell viability was measured using the LIVE/DEAD
Fixable Violet Dead Cell Stain Kit (Invitrogen) according to the
manufacturer’s instructions. The FACSCalibur (BD Biosciences) was
used for analysis of the cellular influx to the peritoneal cavity.
RT-PCR
Total RNA was isolated from peritoneal macrophages either
uninfected or MCMV-infected for 72 h by the TRIzol method
(Invitrogen). RT-PCR was then carried out using the SuperScript
III First-strand Synthesis System for RT-PCR (Invitrogen)
according to the manufacturer’s protocol. Briefly, RNA samples
were treated with RNase-free DNase I (Promega) for 30 min at
37uC, and the DNase was inactivated at 65uC for 10 min. The
RNA was reverse transcribed using oligo(dT) primers at 50uC for
50 min, and reactions were terminated by heating at 85uC for
5 min. The reverse-transcribed products were treated with RNase
H for 20 min at 37uC and amplified using specific primers.
Primers m154For (59- CTT GGA TCC ATG CGG GCG ATG
TTA CGG -39) and m154Rev (59- CTC GGA TCC CAC ATA
AGA CTC GTC ATA -39) were used to amplify a 1116-bp
fragment within the MCMV m154 gene, primers mCD48For (59-
ATG TGC TTC ATA AAA CAG GG -39) and mCD48Rev (59-
TTG TCA GGT TAA CAG GAT CCT GTG -39) were used to
amplify a 726-bp fragment within the murine CD48 gene, and
primers b-actinFor (59- TAT CCT GAC CCT GAA GTA CC -39)
and b-actinRev (59- TCA TCT TTT CAC GGT TGG CC -39)
were used to amplify a 170-bp fragment within the murine b-actin
gene. PCRs were performed under the following conditions: 1
cycle at 94uC for 5 min; 30 cycles of 1 min at 94uC, 1 min at
58uC, and 1 min at 72uC; and 1 cycle at 72uC for 10 min. Control
reactions carried out in the absence of RT were used to assess the
specific detection of RNA. Amplified products were separated on a
1% agarose gel and visualized by ethidium bromide staining.
Western blot analysis
For Western blot analysis, peritoneal murine macrophages,
either mock-infected or infected with MCMV at an moi of 10 were
used. For selective expression of viral immediate-early proteins,
cells were incubated from 30 min prior to infection to 4 h post-
infection in the presence of CHX (100 mg/ml; Sigma Aldrich),
followed by incubation in the presence of actinomycin D (10 mg/
ml; Sigma Aldrich) for another 12 h. Selective expression of early
genes was carried out by treatment of the cells with PPA (250 mg/
ml; Sigma Aldrich) for 72 h. For proteolysis inhibition experi-
ments, cells were treated with 75 mM MG-132 (Sigma Aldrich) or
250 mM leupeptin (Sigma Aldrich) for 6 h and 24 h, respectively,
before harvesting. Under the conditions used, MG-132 and
leupeptin did not generally affect cell viability as assessed by trypan
blue cell staining. At the indicated times after infection for each
specific case, samples were lysed in protein sample buffer and
boiled for 5 min. Cell lysates were subjected to SDS-PAGE in
10% acrylamide gels and subsequently transferred to nitrocellulose
membranes (Protran, Whatman Schleicher & Schuell, Germany).
Equal quantities of total protein were analyzed per lane.
Membranes were probed using the mAb anti-m154 (clone
m154.4.113), mAb anti-IE1 Croma 101, and an anti-mouse IgG
(H+L) HRP as a secondary antibody, and mAb anti-mouse CD48
(HM48-1) followed by a HRP-conjugated goat anti-Armenian
hamster IgG (H+L) antibody. b-actin was detected using the mAb
anti-b-actin and an HRP-conjugated goat anti-rabbit IgG as a
secondary antibody. Blots were developed using a SuperSignal
West Pico Chemiluminescent Substrate (Pierce, Rockford, IL)
according to the manufacturer’s protocol.
Immunofluorescence microscopy
Peritoneal murine macrophages, mock-infected or MCMV-
infected at different mois, were cultured on glass coverslips in 24-
well tissue culture plates. When indicated, cultures were exposed
to proteolysis inhibitors as indicated for the Western blot analysis.
At specific time points after infection, the cells were washed in PBS
and fixed and permeabilized using ice-cold methanol and 0.3%
Triton X-100 (for IE1 detection), or fixed in ice-cold acetone (for
m154 and CD48 detection), and subsequently blocked with 1%
bovine serum albumin (Sigma Aldrich; for IE1 detection) or with
20% rabbit serum (Linus) and 6% fetal bovine serum in PBS (for
m154 and CD48 detection). The cells were stained with anti-m154
mAb (clone m154.4.113), or with MCMV IE1 mAb Croma 101,
using as secondary antibodies a goat anti-mouse IgG (H+L) Alexa
Fluor 555 or Alexa Fluor 488, or directly with anti-mouse CD48-
Alexa Fluor 488. Nuclei were counterstained with DAPI reagent
(Invitrogen). The samples were mounted in ProLong Gold
antifade reagent (Invitrogen). Fluorescence images were obtained
using a Nikon Eclipse E600 microscope (Nikon, Tokyo, Japan) or
an inverted Leica DMI6000B microscope and the LAS AF
software from Leica Microsystems (Wetzlar, Germany).
Immunoprecipitation
Peritoneal macrophages were surface-labeled with biotin (Sigma
Aldrich) and lysed in protein sample buffer. Cell lysates were
precleared 3 times for 30 min using protein G Sepharose (GE
Healthcare) and incubated overnight with anti-m154 mAb and
protein G Sepharose. Immunoprecipitates were washed, eluted,
subjected to SDS-PAGE in 10% acrylamide gels and transferred
to nitrocellulose membranes. Membranes were probed with
streptavidin-POD conjugate (Roche Diagnostics GmbH, Mann-
heim, Germany) and blots developed as for the Western blot
analysis.
Determination of MCMV replication kinetics
Multi-step growth in vitro was analyzed by infecting MEFs or
peritoneal macrophages in 24-well plates with wt MCMV or
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MCMVDm154 at an moi of 0.025 and 0.2, respectively. After a
2 h adsorption period, cells were washed with PBS and incubated
in the corresponding medium supplemented with 3% fetal bovine
serum. At specific time points after infection, the amount of
extracellular (MEFs) or cell-associated (macrophages) infectious
virus present in the cultures was determined as previously
described [65] by a standard plaque assay on MEFs.
NK cell degranulation assays
NK cell degranulation was evaluated using the CD107a
mobilization assay. Cultures of peritoneal macrophages, either
mock-infected or infected with 10 PFU/cell of MCMV or
MCMVDm154 for 72 h, were incubated for 5 h at 37uC with
purified NK cells in the presence of monensin (BD Biosciences)
and anti-CD107a-Alexa Fluor 488, at an effector-to-target cell
ratio (E/T) of 1:1. NK cells treated with 0.5 mg/ml ionomycin
(Sigma Aldrich) and 50 ng/ml PMA (Sigma Aldrich) were used as
a positive control for degranulation. Cells were then washed in
PBS supplemented with 2 mM EDTA, stained for 30 minutes at
4uC with anti-CD49b-PE/Cy7, recognizing DX5, and analyzed
by flow cytometry. When stated, MCMVDm154-infected macro-
phages were pre-incubated with 10 mg/ml of the indicated Fc
fusion protein for 30 min at 37uC, cultures washed, and subjected
to the CD107a mobilization assay using an E/T ratio of 0.5:1.
Mouse infections
Seven-week-old BALB/c.ByJ female mice were obtained from
Harlan (Netherlands) and housed in the vivarium (University of
Barcelona) under specific-pathogen-free conditions. Mice were i.p.
inoculated with 56105 or 26106 PFU of tissue culture-propagated
wt MCMV, MCMVDm154, or MCMVDm154Int recombinants.
When specified, NK cells were depleted by i.p. injection of rabbit
antiserum to asialo GM1 (Wako Pure Chemical Industries, Osaka,
Japan) at a concentration of 25 mg per mouse, one day before
infection and on day 2 after infection. The efficacy of depletion
was assessed by cytofluorometric analyses of spleen cells using an
anti-mouse pan-NK cell mAb CD49b-PE/Cy7. At designated
times after infection, mice were sacrificed, and specific organs were
removed and harvested as a 10% (weight/volume) tissue homog-
enate. Tissue homogenates were sonicated and centrifuged, and
viral titers from the supernatants were determined by standard
plaque assays, including centrifugal enhancement of infectivity
[62] on MEFs. In experiments evaluating the cellular influx to the
peritoneal cavity, mice were sacrificed 2 days after infection and
cells present in the peritoneal cavity harvested with 5 ml of PBS.
Total number of cells were determined with a cell counter, and
stained with a combination of mAbs CD11b-PE and Gr-1-APC or
mAbs CD3-Alexa Fluor 647 and IgM-FITC to distinguish the
different cellular subsets (macrophages [CD11b+ Gr-12], neutro-
phils [CD11b+ Gr-1+], T lymphocytes [CD3+] or B lymphocytes
[IgM+]). The number of peritoneal macrophages infected in vivo
was assessed by IE1 staining of peritoneal lavage-derived
macrophages of mice infected for 16 h with 26106 PFU.
Sequence analysis
The signal peptide cleavage site and the transmembrane region
were predicted by using the SignalP 4.1 (www.cbs.dtu.dk/services/
SignalP/) and the TMHMM 2.0 (www.cbs.dtu.dk/services/
TMHMM-2.0/) servers, respectively. The N-glycosylation and O-
glycosylation motifs of the protein were identified by using the
NetNGlyc 1.0 Server, (www.cbs.dtu.dk/services/NetNGlyc), and
the NetOGlyc 4.0 Server (www.cbs.dtu.dk/services/NetOGlyc/),
respectively.
Statistical analyses
Analyses were performed with GraphPad Prism software
(version 3.03, GraphPad Software, San Diego, CA). Statistical
significance of viral titers between experimental groups was deter-
mined with the Mann-Whitney test (two-tailed). P-values less or
equal to 0.05 (*), 0.01 (**), and 0.001 (***) were considered
statistically significant.
Supporting Information
Figure S1 Similar composition of the cellular influx into
the peritoneal cavity of wt MCMV- and MCMVDm154-
infected mice. Groups of 7-weeks-old BALB/c.ByJ female mice
were i.p. inoculated with 26106 PFU of wt MCMV or
MCMVDm154, or left uninfected. Flow cytometry analysis was
performed on cells extracted from the peritoneal cavity two days
after infection of mice by staining with a combination of mAbs
CD11b-PE and Gr-1-APC, or mAbs CD3-Alexa Fluor 647 and
IgM-FITC. (A) The total cell number and the percentage of
neutrophils (CD11b+ Gr-1+), macrophages (CD11b+ Gr-12), T
lymphocytes (CD3+), and B lymphocytes (IgM+) are indicated.
Data shown are the mean values (6 SEM) of three individual
mice. Differences in values between the wt MCMV and the
MCMVDm154-infected groups are not statistically significant
(p.0.05). (B) Results of the double staining for CD11b-PE and Gr-
1-APC of one representative animal from each group are shown.
(TIF)
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